Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
854 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06275204 | H. Pylori Screen-and-treat Study in a Population of Young Adults | recruiting | — | 6,800 | University of LatviaOTHER | 6 | Mar 5, 2024 | clinicaltrials |
| NCT06274905 | Topical Anaesthesia in Cutaneous Head and Neck Surgery | completed | N/A | 124 | University Hospital WaterfordOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors |
| no longer available |
| — |
| — |
| BayerINDUSTRY |
| 11 |
| Feb 2, 2024 |
| clinicaltrials |
| NCT01584258 | Prostate Advances in Comparative Evidence(PACE) | active not recruiting | Phase 3 | 2,205 | Royal Marsden NHS Foundation TrustOTHER | 4 | Jan 19, 2024 | clinicaltrials |
| NCT01872975 | Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery | active not recruiting | N/A | 1,636 | NSABP Foundation IncNETWORK | 7 | Dec 27, 2023 | clinicaltrials |
| NCT05642988 | Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period | completed | — | 20 | Mater Misericordiae University HospitalOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03230318 | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma(FIDES-01) | completed | Phase 2 | 148 | Basilea PharmaceuticaINDUSTRY | 11 | Dec 19, 2023 | clinicaltrials |
| NCT03980314 | A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection | completed | Phase 1 | 261 | Bristol-Myers SquibbINDUSTRY | 14 | Dec 15, 2023 | clinicaltrials |
| NCT05542485 | PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study(PLAN) | unknown | — | 97 | Royal College of Surgeons, IrelandOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT01864746 | A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery(PENELOPE-B) | completed | Phase 3 | 1,250 | GBG Forschungs GmbHOTHER | 11 | Dec 12, 2023 | clinicaltrials |
| NCT05615285 | Personalised Exercise Rehabilitation for Cancer Survivorship(PERCS) | completed | N/A | 70 | University of Dublin, Trinity CollegeOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT02381249 | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | completed | N/A | 40 | St. James's Hospital, IrelandOTHER | 2 | Nov 27, 2023 | clinicaltrials |
| NCT02385617 | Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer | completed | N/A | 20 | St. James's Hospital, IrelandOTHER | 2 | Nov 27, 2023 | clinicaltrials |
| NCT06115629 | Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial(SARONG-II) | not yet recruiting | Phase 3 | 952 | University of Dublin, Trinity CollegeOTHER | 5 | Nov 3, 2023 | clinicaltrials |
| NCT01849874 | A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer | terminated | Phase 3 | 341 | PfizerINDUSTRY | 19 | Oct 30, 2023 | clinicaltrials |
| NCT04721002 | Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)(MEDICI) | completed | — | 514 | AbbVieINDUSTRY | 22 | Oct 18, 2023 | clinicaltrials |
| NCT03469674 | PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer(PORTEC-4a) | active not recruiting | Phase 3 | 550 | Leiden University Medical CenterOTHER | 8 | Oct 11, 2023 | clinicaltrials |
| NCT01142427 | Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | — | 17,463 | Children's Oncology GroupNETWORK | 7 | Oct 3, 2023 | clinicaltrials |
| NCT03302234 | Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598) | completed | Phase 3 | 568 | Merck Sharp & Dohme LLCINDUSTRY | 24 | Sep 26, 2023 | clinicaltrials |
| NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck(CheckMate 651) | completed | Phase 3 | 947 | Bristol-Myers SquibbINDUSTRY | 18 | Sep 21, 2023 | clinicaltrials |
| NCT06014398 | Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours | unknown | N/A | 50 | Royal College of Surgeons, IrelandOTHER | 1 | Aug 28, 2023 | clinicaltrials |
| NCT02755597 | A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy(Bellini) | completed | Phase 3 | 291 | AbbVieINDUSTRY | 16 | Aug 22, 2023 | clinicaltrials |
| NCT03024996 | A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy(IMmotion010) | terminated | Phase 3 | 778 | Hoffmann-La RocheINDUSTRY | 28 | Aug 3, 2023 | clinicaltrials |
| NCT03997643 | Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial | recruiting | Phase 2 | 90 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 4 | Aug 3, 2023 | clinicaltrials |
| NCT05648955 | Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment(ALLIES) | unknown | Early Phase 1 | 118 | Nutricia ResearchINDUSTRY | 1 | Jul 28, 2023 | clinicaltrials |
| NCT05263557 | Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)(DIMOXIS) | unknown | N/A | 20 | Royal College of Surgeons, IrelandOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT05921279 | Understanding CARdiac Events in Breast Cancer(UCARE) | unknown | — | 100 | National University of Ireland, Galway, IrelandOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT01964430 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)(apact) | completed | Phase 3 | 866 | CelgeneINDUSTRY | 21 | Jun 28, 2023 | clinicaltrials |
| NCT02285062 | Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma(ROBUST) | completed | Phase 3 | 570 | CelgeneINDUSTRY | 21 | Jun 22, 2023 | clinicaltrials |
| NCT02952534 | A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency(TRITON2) | completed | Phase 2 | 277 | pharmaand GmbHINDUSTRY | 12 | Jun 9, 2023 | clinicaltrials |
| NCT01734928 | Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma(OPTIMISMM) | completed | Phase 3 | 559 | CelgeneINDUSTRY | 22 | Jun 6, 2023 | clinicaltrials |
| NCT05816460 | The Sleepio After Cancer Study(SACS) | unknown | N/A | 308 | University College DublinOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT02573324 | A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification(Intellance1) | completed | Phase 3 | 691 | AbbVieINDUSTRY | 28 | May 11, 2023 | clinicaltrials |
| NCT03657043 | A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) | completed | Phase 2 | 98 | Seagen Inc.INDUSTRY | 6 | May 6, 2023 | clinicaltrials |
| NCT02823574 | Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck(CheckMate 714) | completed | Phase 2 | 425 | Bristol-Myers SquibbINDUSTRY | 21 | May 3, 2023 | clinicaltrials |
| NCT02756611 | A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)(VENICE I) | completed | Phase 3 | 258 | AbbVieINDUSTRY | 21 | Apr 10, 2023 | clinicaltrials |
| NCT03642132 | Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) | terminated | Phase 3 | 79 | PfizerINDUSTRY | 10 | Apr 6, 2023 | clinicaltrials |
| NCT00251433 | GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer | terminated | Phase 1 | 53 | Novartis PharmaceuticalsINDUSTRY | 3 | Mar 31, 2023 | clinicaltrials |
| NCT04932317 | Oral Symptom Assessment Scale (OSAS): Validity and Reliability | completed | — | 54 | Our Lady's Hospice and Care ServicesOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT05074069 | A Review of Functional and Surgical Outcomes of Gynaecological Reconstruction in the Context of Pelvic Exenteration | completed | — | 334 | St Vincent's University Hospital, IrelandOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT05074082 | Perineal Flap Reconstruction Following Surgery for Advanced Pelvic Malignancy | completed | — | 883 | St Vincent's University Hospital, IrelandOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT00470236 | Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast(DCIS) | unknown | N/A | 1,608 | Trans Tasman Radiation Oncology GroupOTHER | 11 | Mar 22, 2023 | clinicaltrials |
| NCT05773183 | Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men(MMetdMH) | unknown | — | 60 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT04924010 | Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients | completed | N/A | 48 | Mater Misericordiae University HospitalOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT03909386 | Non-interventional Study on Patients With Atrial Fibrillation and Cancer(BLITZ-AFCancer) | completed | — | 1,514 | Heart Care FoundationOTHER | 6 | Jan 12, 2023 | clinicaltrials |
| NCT04312737 | Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus(EU-VALHUDES) | completed | — | 600 | Hiantis SrlINDUSTRY | 3 | Jan 6, 2023 | clinicaltrials |
| NCT04766229 | The Menopause After Cancer Study(MACS) | completed | Phase 2 | 205 | University College DublinOTHER | 1 | Jan 6, 2023 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials